Molecular Oncology
Volume 2, Issue 1 , Pages 94-101 , June 2008

3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs

  • Linda Strandberg Ihrlund

      Affiliations

    • These authors are equal contributors.
    • ,
  • Emma Hernlund

      Affiliations

    • These authors are equal contributors.
    • ,
  • Omar Khan

      Affiliations

    • Present address: Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
    • ,
  • Maria C. Shoshan

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +64 8 51 77 54 60; fax: +46 8 33 90 31.

Received 27 September 2007 ,Revised 4 January 2008 ,Accepted 8 January 2008.

References 

  1. Berndtsson M, Hägg M, Panaretakis T, Mandic Havelka A, Shoshan MC, Linder S. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int. J. Cancer. 2007;120:175–180
  2. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology:new insights into their cellular reduction. Biotechn. Annu. Rev. 2005;11:127–152
  3. Cuezva JM, Krajewska M, López de Heredia M, Krajewski S, Santamaría G, Kim H, et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 2002;62:6674–6681
  4. Dell'antone P. Inactivation of H(+)-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent. Life Sci. 2006;79:2049–2055
  5. Hägg M, Biven K, Ueno T, et al. A novel high-throughput assay for screening of pro-apoptotic drugs. Invest. New Drugs. 2002;20:253–259
  6. Harper ME, Antoniou A, Villalobos-Menuey E, et al. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J. 2002;16:1550–1557
  7. Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis. 2005;26:2095–2104
  8. Kim J, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66:8927–8930
  9. Ko YH, Pedersen PL, Geschwind JF. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 2001;173:83–91
  10. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, et al. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem. Biophys. Res. Commun. 2004;324:269–275
  11. Kramer G, Erdal H, Mertens HJ, Nap M, Mauermann J, Steiner G, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004;64:1751–1756
  12. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, et al. 2-Deoxyglucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 2004;64:31–34
  13. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science. 2006;312:1650–1653
  14. Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli BA, et al. Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 1996;35:103–111
  15. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab. Rev. 2007;39:443–455
  16. Pedersen PL. The cancer cell's “power plants” as promising therapeutic targets: An overview. J. Bioenerg. Biomembr. 2007;39:1–12
  17. Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metabol. 2002;13:74–78
  18. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death?. Exp. Cell Res. 2003;283:1–16
  19. Shaw RJ. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 2006;18:1–11
  20. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol. Med. Today. 2000;6:15–19
  21. Tan AS, Berridge MV. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J. Immunol. Methods. 2000;238:59–68
  22. Tomida A, Suzuki H, Kim HD, Tsuruo T. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of Rb protein in human cancer cells. Oncogene. 1996;13:2699–2705
  23. Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65:613–621
  24. Yamada M, Tomida A, Yun J, Cai B, Yoshikawa H, Taketani Y, et al. Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-related stress. Cancer Chemother. Pharmacol. 1999;44:59–64

PII: S1574-7891(08)00004-5

doi: 10.1016/j.molonc.2008.01.003

Molecular Oncology
Volume 2, Issue 1 , Pages 94-101 , June 2008

Article Tools

* Image Usage & Resolution